Phase I trial of daily imatinib mesylate and weekly paclitaxel in patients with advanced refractory solid tumors

被引：0
|
作者：
Bahrani, A [1 ]
Hwang, J [1 ]
Malik, S [1 ]
Marshall, JL [1 ]
机构：
[1] Georgetown Univ Hosp, Washington, DC 20007 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3087
引用
收藏
页码：216S / 216S
页数：1
相关论文
共 50 条
  • [21] Phase I and pharmacokinetic study of weekly docetaxel, cisplatin, and daily capecitabine in patients with advanced solid tumors
    Fakih, MG
    Creaven, PJ
    Ramnath, N
    Trump, D
    Javle, M
    Strychor, S
    Repinski, TV
    Zamboni, BA
    Schwarz, JK
    French, RA
    Zamboni, WC
    CLINICAL CANCER RESEARCH, 2005, 11 (16) : 5942 - 5949
  • [22] Phase I study of weekly vinorelbine in combination with weekly paclitaxel in adult patients with advanced refractory cancer
    Cohen, RB
    Mueller, SC
    Haden, K
    de Souza, P
    CANCER INVESTIGATION, 2000, 18 (05) : 422 - 428
  • [23] Phase I study of bortezomib with weekly paclitaxel in patients with advanced solid tumours
    Cresta, S.
    Sessa, C.
    Catapano, C. V.
    Gallerani, E.
    Passalacqua, D.
    Rinaldi, A.
    Bertoni, F.
    Vigano, L.
    Maur, M.
    Capri, G.
    Maccioni, E.
    Tosi, D.
    Gianni, L.
    EUROPEAN JOURNAL OF CANCER, 2008, 44 (13) : 1829 - 1834
  • [24] Phase I Study of Imatinib Mesylate (Gleevec) and Gemcitabine in Patients with Refractory Solid Tumor Malignancy
    Ali, Yaqoob
    Poplin, Elizabeth A.
    Gharibo, Mecide
    Stein, Mark
    Lagattuta, Theodore
    Murugesan, Gounder
    Egorin, Merrill
    Rubin, Eric
    CANCER RESEARCH, 2006, 66 (08)
  • [25] Phase I/II trial of weekly paclitaxel in patients with advanced lung cancer
    Akerley, W
    SEMINARS IN ONCOLOGY, 1996, 23 (06) : 55 - 58
  • [26] Phase I clinical trial of STA-4783 in combination with paclitaxel in patients with refractory solid tumors
    Berkenblit, Anna
    Eder, Joseph P., Jr.
    Ryan, David P.
    Seiden, Michael V.
    Tatsuta, Noriaki
    Sherman, Matthew L.
    Dahl, Thomas A.
    Dezube, Bruce J.
    Supko, Jeffrey G.
    CLINICAL CANCER RESEARCH, 2007, 13 (02) : 584 - 590
  • [27] Phase I trial of paclitaxel and gemcitabine administered every two weeks in patients with refractory solid tumors
    Rothenberg, ML
    Sharma, A
    Weiss, GR
    Villalona-Calero, MA
    Eckardt, JR
    Aylesworth, C
    Kraynak, MA
    Rinaldi, DA
    Rodriguez, GI
    Burris, HA
    Eckhardt, SG
    Stephens, CD
    Forral, K
    Nicol, SJ
    Von Hoff', DD
    ANNALS OF ONCOLOGY, 1998, 9 (07) : 733 - 738
  • [28] Phase I Trial of Weekly Topotecan and Gemcitabine in Patients With Solid Tumors
    William, William N., Jr.
    Lee, Joseph L.
    Shin, Dong M.
    Hong, Waun K.
    Liu, Suyu
    Lee, J. Jack
    Lippman, Scott M.
    Khuri, Fadlo R.
    Kim, Edward S.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2009, 32 (01): : 15 - 19
  • [29] A phase I study of cilengitide and paclitaxel in patients with advanced solid tumors
    Haddad, Tufia
    Qin, Rui
    Lupu, Ruth
    Satele, Daniel
    Eadens, Matthew
    Goetz, Matthew P.
    Erlichman, Charles
    Molina, Julian
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 79 (06) : 1221 - 1227
  • [30] A phase I study of cilengitide and paclitaxel in patients with advanced solid tumors
    Tufia Haddad
    Rui Qin
    Ruth Lupu
    Daniel Satele
    Matthew Eadens
    Matthew P. Goetz
    Charles Erlichman
    Julian Molina
    Cancer Chemotherapy and Pharmacology, 2017, 79 : 1221 - 1227
12345